{"page_content": "Notes\nNote 7 \u2013 Information on staff and remuneration (continued)\nEmployee warrant programs\nIncentive programs have been offered in 2005, 2007 and in the 2009-2020 period. No new warrant pro-grams were issued in 2021.\n The employee incentive programs of\nW\narrant programs existing during the period\n    2020\n 2015\nMaximum years o\nf options granted\n     10 years\n 5 years\nMethod o\nf settlement \n     equity-settled\n equity-settled\n   \n2021\n   \nOutstanding a\nt the beginning of the period\n    63\n,217\n 1,\n908,920\nGranted during the period\n     0\n 0\nForf\neited during the period\n     0\n -21\n4,348\nExercised during the period\n     0\n -233\n,595\nExpired during the period\n     0\n -47\n,000\nOutstanding at the end of the period \n     63\n,217\n 1,\n413,977\nExercisable at the end of the period\n     21,\n073\n 529\n,596\n   \nW\narrants outstanding at the end of the period\n   \nRange o\nf exercise prices\n     216\n.8\n 90-22\n4.4\nWeighted-average remaining contractual life\n    8\n.7\n 3\n.8\nNumber held by Executive Management\n     0\n 353\n,409\nThe Board of directors have not been granted warrants. The employee incentive programs of\nW\narrant programs existing during the period\n   2020\n 2015\n 2010\nMaximum years o\nf options granted\n    10 years\n 5 years\n 5 years\nMethod o\nf settlement \n    equity-settled \n equity-settled\n   \n2020\n   \nOutstanding a\nt the beginning of the period\n   0\n 1,\n647,788\n 42,359\nGranted during the period\n    63\n,217\n 631,288\n 0\nForf\neited during the period\n    0\n -53\n,747\n 0\nEx\nercised during the period\n    0\n -276\n,409\n -42,359\nExpir\ned during the period\n    0\n -40\n,000\n 0\nOutstanding a\nt the end of the period \n    63\n,217\n 1,\n908,920\n 0\nEx\nercisable at the end of the period\n    0\n 301,529\n 0\n   \nW\narrants outstanding at the end of the period\n   \nRange o\nf exercise prices\n    216\n.8\n 90\n.0-224.4\n 101.2-127\n.1\nWeighted-average remaining contractual life\n   9\n.7\n 4\n.9\n 0\nNumber held by Ex\necutive Management\n    0\n 373\n,409\n 067\nZealand Pharma  \u221e  Annual Report 2021", "metadata": {"source": "NASDAQ_ZEAL_2021.pdf", "page": 66, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}